Liquid chromatographic/tandem mass spectrometric method for the quantitation of tranilast in human plasma.
暂无分享,去创建一个
Jian Wang | J. P. Fawcett | J. Gu | Dan Wu | Jing Lan | Yingwu Wang
[1] R. B. Walker,et al. An LC-MS-MS method for the determination of cyclizine in human serum. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[2] H. Padh,et al. Analytical method development and validation of mianserin hydrochloride and its metabolite in human plasma by LC-MS. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[3] T. Saruta,et al. Tranilast inhibits interleukin-1beta-induced monocyte chemoattractant protein-1 expression in rat mesangial cells. , 2001, European journal of pharmacology.
[4] M. Fujii,et al. Effect of UV-absorbing agents on photodegradation of tranilast in oily gels. , 1999, Chemical & pharmaceutical bulletin.
[5] H. Miyata,et al. Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats. , 1998, Life sciences.
[6] H. Ikeda,et al. Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells. , 1996, Biochemical and biophysical research communications.
[7] T. Arita,et al. High-performance liquid chromatographic determination of tranilast in plasma. , 1985, Journal of chromatography.
[8] J. Hsieh,et al. Simultaneous determination of tranilast and metabolites in plasma and urine using high-performance liquid chromatography. , 1985, Journal of chromatography.